Abbott Laboratories
NYSE:ABT
Abbott Laboratories
NYSE:ABT
Price:
107.28 USD
1.91%
Market Closed
Updated:
Apr 20, 2024
Abbott Laboratories
Cash from Operating Activities
Last
Value
3-Years CAGR
5-Years CAGR
|
Abbott Laboratories
Cash from Operating Activities Peer Comparison
Comparables:
BDX
BSX
EW
SYK
ISRG
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Abbott Laboratories
NYSE:ABT
|
Cash from Operating Activities
$7.3B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
4%
|
CAGR 10-Years
9%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Cash from Operating Activities
$3.4B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
4%
|
CAGR 10-Years
8%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Cash from Operating Activities
$2.5B
|
CAGR 3-Years
18%
|
CAGR 5-Years
52%
|
CAGR 10-Years
8%
|
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Cash from Operating Activities
$895.8m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
7%
|
|
|
Stryker Corp
NYSE:SYK
|
Cash from Operating Activities
$3.7B
|
CAGR 3-Years
4%
|
CAGR 5-Years
7%
|
CAGR 10-Years
7%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Cash from Operating Activities
$1.8B
|
CAGR 3-Years
7%
|
CAGR 5-Years
9%
|
CAGR 10-Years
8%
|
See Also
What is Abbott Laboratories's Cash from Operating Activities?
Cash from Operating Activities
7.3B
USD
7.3B
USD
Based on the financial report for Mar 31, 2024, Abbott Laboratories's Cash from Operating Activities amounts to 7.3B USD.
What is Abbott Laboratories's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
9%
9%
Over the last year, the Cash from Operating Activities growth was -16%. The average annual Cash from Operating Activities growth rates for Abbott Laboratories have been -10% over the past three years , 4% over the past five years , and 9% over the past ten years .
You don't have any saved screeners yet
